MKLNF (M1 Kliniken AG) Other Financing: $-12.3 Mil (TTM As of Dec. 2025)


MKLNF M1 Kliniken AG MKLNF
92 GF Score
Price $11.73
GF Value $9.85
! 4 Warning Signs
View Full Analysis

What is M1 Kliniken AG Other Financing?

M1 Kliniken AG MKLNF 92 Other Financing is $-12.3 Mil as of Dec. 2025. GuruFocus rates MKLNF with a GF Score™ of 92/100 and a GF Value™ of $9.85. The stock has 4 warning signs investors should review.

M1 Kliniken AG's Other Financing for the six months ended in Dec. 2025 was $-11.5 Mil.

M1 Kliniken AG's Other Financing for the trailing twelve months (TTM) ended in Dec. 2025 was $-12.3 Mil.

M1 Kliniken AG Other Financing Historical Data

* Premium members only.

The historical data trend for M1 Kliniken AG's Other Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

M1 Kliniken AG Other Financing Chart

M1 Kliniken AG Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Financing
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.57 -0.42 -0.97 -1.60 -1.41

M1 Kliniken AG Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Other Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.46 -0.84 -10.54 -0.79 -11.51
MKLNF
92GF Score
M1 Kliniken AG MKLNF
Other Financing is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

M1 Kliniken AG Other Financing Calculation

Other Financing represents other cash flow from financing activity that not otherwise classified, which includes:
Proceeds From Stock Option Exercised
Other Financing Charges

Other Financing for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $-12.3 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Other Financing →
What does a Other Financing of $-12.3 Mil mean?
M1 Kliniken AG (MKLNF) has a Other Financing of $-12.3 Mil as of Dec. 2025. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for M1 Kliniken AG and its competitors.
Is M1 Kliniken AG's Other Financing too high?
M1 Kliniken AG's current Other Financing is $-12.3 Mil. Overall, M1 Kliniken AG has a GF Score™ of 92/100, reflecting its overall financial health beyond just this single metric.
How does M1 Kliniken AG's Other Financing compare to MCK and CAH?
M1 Kliniken AG's Other Financing of $-12.3 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Financing for a Medical Distribution company?
A good Other Financing depends on the Medical Distribution industry context. However, Other Financing should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Financing mean?
A high Other Financing can signal that a stock is expensive relative to its fundamentals. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for M1 Kliniken AG and its competitors. M1 Kliniken AG's current Other Financing is $-12.3 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is M1 Kliniken AG stock overvalued right now?
M1 Kliniken AG (MKLNF) has a current Other Financing of $-12.3 Mil. The stock's GF Value™ is $9.85, compared to a current price of $11.73 — trading 19.1% above its estimated fair value. The current Other Financing is $-12.3 Mil. M1 Kliniken AG's overall GF Score™ is 92/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Financing calculated?
Other Financing is calculated from a company's financial statements. For M1 Kliniken AG (MKLNF), the current Other Financing is $-12.3 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is M1 Kliniken AG (MKLNF) Overvalued in 2026?

Based on GuruFocus' analysis, M1 Kliniken AG stock appears to be overvalued. The current stock price of $11.73 is trading 19.1% above its estimated GF Value™ of $9.85.

Key valuation signals for MKLNF:

  • Other Financing: $-12.3 Mil
  • GF Value™: $9.85 vs. price of $11.73 (19.1% above fair value)
  • GF Score™: 92/100 with 4 warning signs

No single metric tells the full story. See the MKLNF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

M1 Kliniken AG Business Description

Other Exchanges M12:Germany
Address Grunauer strasse 5, Berlin, BB, DEU, 12557
M1 Kliniken AG operates in the growing market of aesthetic medicine and plastic surgery and provides aesthetic medical treatments in the self-pay segment. It operates through Beauty and Trade segments. Its activities are focused on providing aesthetic medical treatment. In addition to medical aesthetic treatments, the company also develops and markets pharmaceutical, medical, and medical technology products for aesthetic surgery and cosmetic dermatology. Some of the treatments offered by the group are lip under injection, eyebrow lift, tummy tuck, breast reduction, sweat treatment, liposuction, and others. The organization conducts its business operations in Germany. The majority of its revenue is derived from the Trade segment.
92GF Score

Get the complete analysis for MKLNF

Other Financing is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$11.73
Price
$9.85
GF Value